Different sensitivity of CD19-positive bone marrow and lymph node lymphoblasts may cause resistance to blinatumomab in relapsed B-cell acute lymphoblastic leukemia/lymphoma
暂无分享,去创建一个
H. Lepidi | R. Costello | J. Colle | I. Arnoux | G. Venton | L. Farnault | C. Colavolpe | R. Fanciullino | Y. Berda-Haddad | V. Ivanov | C. Mercier | C. Nicolino‐Brunet | Gleb Ivanov